USE OF FCRN ANTAGONISTS FOR THE TREATMENT OF GENERALIZED MYASTHENIA SEVERE
MA51032AUndetermined Publication Date: 2021-03-17ARGENX BVBA(BE)
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA51032
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2017-12-08
- Filing Date
- 2018-12-07
- Publication Date
- 2021-03-17
Need to check novelty before this filing date? Find Prior Art
No text content released.